Thailand IVD Market Growth Stats

Thailand’s In Vitro Diagnostics (IVD) market is projected to grow from approximately USD 1.03 billion in 2023 to USD 1.63 billion by 2030, with a CAGR of 6.3% from 2024 to 2030. Key growth drivers include rising chronic disease prevalence, an aging population, and government healthcare initiatives.

Thailand IVD Market Overview

1.03
Billion USD

2023 Market Size

478.2
Million USD

2025 Forecast (Statista estimate at manufacturer price level)

1.63
Billion USD

NextMSC full market estimate

6.3%
CAGR

(2024-2030)

Segment Highlight:
Infectious disease IVD segment alone is expected to grow at 6.6% CAGR from 2025 to 2030

JOIN US

Key Growth Drivers

  • Chronic Disease Burden: Non-communicable diseases (NCDs) like cancer, diabetes, and cardiovascular conditions are major contributors to mortality in Thailand. This drives demand for early detection and routine monitoring.

  • Aging Population: Nearly 20% of Thailand’s population is over 60, increasing the need for diagnostic services.

  • Government Initiatives: Thailand’s healthcare modernization efforts and preventive care campaigns are expanding access to diagnostics.

  • Technological Advancements: Adoption of molecular diagnostics, immunoassays, and point-of-care testing is accelerating, especially in hospital and retail settings.

  • Infectious Disease Surveillance: Continued investment in infectious disease diagnostics, particularly post-COVID, supports market expansion.

Sources:  Sources: Statista, NextMSC & Grand View Research